Global Gastric Antral Vascular Ectasia (GAVE) Treatment Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Gastric Antral Vascular Ectasia (GAVE) Treatment Market, By Treatment (Surgery, Medical Therapy, Endoscopy), End-User (Research Institutes, Hospitals, Others), Distribution Channel (Hospital Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Gastric Antral Vascular Ectasia (GAVE) Treatment Market Market Analysis and Insights: Global Gastric Antral Vascular Ectasia (GAVE) Treatment Market

The gastric antral vascular ectasia (GAVE) treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 3.80% in the above-mentioned research forecast period. The research regarding the gastric antral vascular ectasia (GAVE) treatment can be one of the factors for the growth of the gastric antral vascular ectasia (GAVE) treatment market.

Gastric antral vascular ectasia (GAVE) which is also known as watermelon stomach is rare disease which is related to gastrointestinal bleeding and iron deficiency anemia. It is characterized by the different endoscopic appearance of roughly formed parallel folds and the blood vessels which are dilated are departing from the pylorus and are uniting in the gastric antrum. The symptoms for GAVI are blood loss which is one of the main concerns for the patients suffering from the uncommon disease. Other symptoms are blood in stool or during vomiting, internal bleeding can be shown if the blood test is performed on the regular basis.

Increase in risk factors that can cause GAVE are proliferation of neuroendocrine cells, hypergastrinemia, changes in the level of prostaglandin E2 hormone, asoactive intestinal polypeptide, 5-hydroxytryptamine are some of the risk factors that can drive the gastric antral vascular ectasia (GAVE) treatment market growth. Gastric antral vascular ectasia (GAVE) is the expanded form of various other diseases such as chronic renal failure, diabetes, hypertension, pulmonary disease, hepatic cirrhosis and it mainly causes older population, therefore increase in aging population are the factors which can drive the gastric antral vascular ectasia (GAVE) treatment market growth. However, the pathophysiological changes which causes GAVE are still unknown and complications related to the surgery which is one of the treatment options of GAVI and can act as a restraining factor for the gastric antral vascular ectasia (GAVE) treatment market growth.   

Increase in healthcare expenditure and disposable income of the population is considered as an opportunity for the gastric antral vascular ectasia (GAVE) treatment market growth. But there are less study related to which treatment is more effective for the GAVI which is still unknown and is one of the challenging factors for the gastric antral vascular ectasia (GAVE) treatment market growth.         

This gastric antral vascular ectasia (GAVE) treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the gastric antral vascular ectasia (GAVE) treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Gastric Antral Vascular Ectasia (GAVE) Treatment Market Scope and Market Size

The gastric antral vascular ectasia (GAVE) treatment market is segmented on the basis of treatment, end-user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of treatment, the gastric antral vascular ectasia (GAVE) treatment market is segmented into surgery, medical therapy and endoscopy. Endoscopy is further segmented to argon plasma coagulation, endoscopic band ligation and radiofrequency ablation. Medical therapy is further segmented to hormonal therapy, somatostatin analogue and others. Hormonal therapy is further segmented to estrogen and progesterone. Somatostatin analogue is further segmented to octreotide. Others are further segmented to tranexamic acid.
  • On the basis of end-user, the gastric antral vascular ectasia (GAVE) treatment market is segmented to research institutes, hospitals and others.
  • On the basis of distribution channel, the gastric antral vascular ectasia (GAVE) treatment market is segmented into hospital pharmacy and others

Global Gastric Antral Vascular Ectasia (GAVE) Treatment Market Country Level Analysis

Global gastric antral vascular ectasia (GAVE) treatment market is analysed and market size information is provided by the country, treatment, end-user and distribution channel as referenced above.

The countries covered in the gastric antral vascular ectasia (GAVE) treatment market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America dominates the gastric antral vascular ectasia (GAVE) treatment market due to the rising investments by hospitals to purchase new endoscopic equipment and growing research activities to enhance endoscopy.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The gastric antral vascular ectasia (GAVE) treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to gastric antral vascular ectasia (GAVE) treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the gastric antral vascular ectasia (GAVE) treatment market in the growth period.

Competitive Landscape and Global Gastric Antral Vascular Ectasia (GAVE) Treatment Market Share Analysis

The gastric antral vascular ectasia (GAVE) treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to gastric antral vascular ectasia (GAVE) treatment market.

The major players covered in the global gastric antral vascular ectasia (GAVE) treatment market report are Olympus, B. Braun Melsungen Ag, Ethicon, Boston Scientific, Fujifilm Corporation, Cook Medical, Medtronic, Hoya Corporation, Richard Wolf GmbH, KARL STORZ, Stryker, Boston Scientific, Hoya Corporation, Richard Wolf GmbH, Smith & Nephew, Cook Medical and B. Braun Melsungen AG among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Gastric Antral Vascular Ectasia (GAVE) Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions